 | • レポートコード：D0GIR-12957 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ケトロラック注射の世界市場を広く調査・分析し、今後の市場展望をまとめております。ケトロラック注射の種類別市場規模（15mg/ml、30mg/ml）、用途別市場規模（病院、クリニック、回復センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Almaject、Athenex、Hikma、Amphastar、Alvogen、Fresenius Kabi、Fosun Pharma、Sagent、Pfizer、BD RX、Virtus Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・ケトロラック注射の北米市場（アメリカ、カナダ、メキシコ） ・ケトロラック注射のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ケトロラック注射のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ケトロラック注射の南米市場（ブラジル、アルゼンチン） ・ケトロラック注射の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：15mg/ml、30mg/ml ・用途別分析：病院、クリニック、回復センター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Ketorolac Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Ketorolac Injection sales will be xx in 2020 from Ketorolac Injection million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Ketorolac Injection market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Ketorolac Injection industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Ketorolac Injection and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Ketorolac Injection market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Ketorolac Injection market has been segmented into
15mg/ml
30mg/ml
By Application, Ketorolac Injection has been segmented into:
Hospital
Clinics
Recovery Center
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ketorolac Injection market presented in the report. This section sheds light on the sales growth of different regional and country-level Ketorolac Injection markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ketorolac Injection market.
The report offers in-depth assessment of the growth and other aspects of the Ketorolac Injection market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Ketorolac Injection Market Share Analysis
Ketorolac Injection competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ketorolac Injection sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ketorolac Injection sales, revenue and market share for each player covered in this report.
The major players covered in Ketorolac Injection are:
Almaject
Athenex
Hikma
Amphastar
Alvogen
Fresenius Kabi
Fosun Pharma
Sagent
Pfizer
BD RX
Virtus Pharmaceuticals
Among other players domestic and global, Ketorolac Injection market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ketorolac Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ketorolac Injection, with price, sales, revenue and global market share of Ketorolac Injection in 2018 and 2019.
Chapter 3, the Ketorolac Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ketorolac Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Ketorolac Injection market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Ketorolac Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Ketorolac Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ketorolac Injection Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 15mg/ml
1.2.3 30mg/ml
1.3 Market Analysis by Application
1.3.1 Overview: Global Ketorolac Injection Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Recovery Center
1.4 Overview of Global Ketorolac Injection Market
1.4.1 Global Ketorolac Injection Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Ketorolac Injection Industry Impact
1.6.1 COVID-19 Potential Implications for the Ketorolac Injection
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Ketorolac Injection
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Almaject
2.1.1 Almaject Details
2.1.2 Almaject Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Almaject SWOT Analysis
2.1.4 Almaject Product and Services
2.1.5 Almaject Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Athenex
2.2.1 Athenex Details
2.2.2 Athenex Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Athenex SWOT Analysis
2.2.4 Athenex Product and Services
2.2.5 Athenex Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hikma
2.3.1 Hikma Details
2.3.2 Hikma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Hikma SWOT Analysis
2.3.4 Hikma Product and Services
2.3.5 Hikma Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amphastar
2.4.1 Amphastar Details
2.4.2 Amphastar Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amphastar SWOT Analysis
2.4.4 Amphastar Product and Services
2.4.5 Amphastar Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Alvogen
2.5.1 Alvogen Details
2.5.2 Alvogen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Alvogen SWOT Analysis
2.5.4 Alvogen Product and Services
2.5.5 Alvogen Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Fresenius Kabi
2.6.1 Fresenius Kabi Details
2.6.2 Fresenius Kabi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Fresenius Kabi SWOT Analysis
2.6.4 Fresenius Kabi Product and Services
2.6.5 Fresenius Kabi Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Fosun Pharma
2.7.1 Fosun Pharma Details
2.7.2 Fosun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Fosun Pharma SWOT Analysis
2.7.4 Fosun Pharma Product and Services
2.7.5 Fosun Pharma Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sagent
2.8.1 Sagent Details
2.8.2 Sagent Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sagent SWOT Analysis
2.8.4 Sagent Product and Services
2.8.5 Sagent Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 BD RX
2.10.1 BD RX Details
2.10.2 BD RX Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 BD RX SWOT Analysis
2.10.4 BD RX Product and Services
2.10.5 BD RX Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Virtus Pharmaceuticals
2.11.1 Virtus Pharmaceuticals Details
2.11.2 Virtus Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Virtus Pharmaceuticals SWOT Analysis
2.11.4 Virtus Pharmaceuticals Product and Services
2.11.5 Virtus Pharmaceuticals Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Ketorolac Injection Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Ketorolac Injection Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Ketorolac Injection Manufacturer Market Share in 2019
3.3.2 Top 6 Ketorolac Injection Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Ketorolac Injection Sales, Revenue and Market Share by Regions
4.1.1 Global Ketorolac Injection Sales and Market Share by Regions (2015-2020)
4.1.2 Global Ketorolac Injection Revenue and Market Share by Regions (2015-2020)
4.2 North America Ketorolac Injection Sales and Growth Rate (2015-2020)
4.3 Europe Ketorolac Injection Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Ketorolac Injection Sales and Growth Rate (2015-2020)
4.5 South America Ketorolac Injection Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Ketorolac Injection Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Ketorolac Injection Sales, Revenue and Market Share by Country
5.1.1 North America Ketorolac Injection Sales and Market Share by Country (2015-2020)
5.1.2 North America Ketorolac Injection Revenue and Market Share by Country (2015-2020)
5.2 United States Ketorolac Injection Sales and Growth Rate (2015-2020)
5.3 Canada Ketorolac Injection Sales and Growth Rate (2015-2020)
5.4 Mexico Ketorolac Injection Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Ketorolac Injection Sales, Revenue and Market Share by Country
6.1.1 Europe Ketorolac Injection Sales and Market Share by Country (2015-2020)
6.1.2 Europe Ketorolac Injection Revenue and Market Share by Country (2015-2020)
6.2 Germany Ketorolac Injection Sales and Growth Rate (2015-2020)
6.3 UK Ketorolac Injection Sales and Growth Rate (2015-2020)
6.4 France Ketorolac Injection Sales and Growth Rate (2015-2020)
6.5 Russia Ketorolac Injection Sales and Growth Rate (2015-2020)
6.6 Italy Ketorolac Injection Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Ketorolac Injection Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Ketorolac Injection Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Ketorolac Injection Revenue and Market Share by Regions (2015-2020)
7.2 China Ketorolac Injection Sales and Growth Rate (2015-2020)
7.3 Japan Ketorolac Injection Sales and Growth Rate (2015-2020)
7.4 Korea Ketorolac Injection Sales and Growth Rate (2015-2020)
7.5 India Ketorolac Injection Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Ketorolac Injection Sales and Growth Rate (2015-2020)
7.7 Australia Ketorolac Injection Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Ketorolac Injection Sales, Revenue and Market Share by Country
8.1.1 South America Ketorolac Injection Sales and Market Share by Country (2015-2020)
8.1.2 South America Ketorolac Injection Revenue and Market Share by Country (2015-2020)
8.2 Brazil Ketorolac Injection Sales and Growth Rate (2015-2020)
8.3 Argentina Ketorolac Injection Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Ketorolac Injection Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Ketorolac Injection Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Ketorolac Injection Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Ketorolac Injection Sales and Growth Rate (2015-2020)
9.3 Turkey Ketorolac Injection Sales and Growth Rate (2015-2020)
9.4 Egypt Ketorolac Injection Sales and Growth Rate (2015-2020)
9.5 South Africa Ketorolac Injection Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Ketorolac Injection Sales and Market Share by Type (2015-2020)
10.2 Global Ketorolac Injection Revenue and Market Share by Type (2015-2020)
10.3 Global Ketorolac Injection Price by Type (2015-2020)
11 Global Ketorolac Injection Market Segment by Application
11.1 Global Ketorolac Injection Sales Market Share by Application (2015-2020)
11.2 Global Ketorolac Injection Revenue Market Share by Application (2015-2020)
11.3 Global Ketorolac Injection Price by Application (2015-2020)
12 Market Forecast
12.1 Global Ketorolac Injection Sales, Revenue and Growth Rate (2021-2025)
12.2 Ketorolac Injection Market Forecast by Regions (2021-2025)
12.2.1 North America Ketorolac Injection Market Forecast (2021-2025)
12.2.2 Europe Ketorolac Injection Market Forecast (2021-2025)
12.2.3 Asia-Pacific Ketorolac Injection Market Forecast (2021-2025)
12.2.4 South America Ketorolac Injection Market Forecast (2021-2025)
12.2.5 Middle East & Africa Ketorolac Injection Market Forecast (2021-2025)
12.3 Ketorolac Injection Market Forecast by Type (2021-2025)
12.3.1 Global Ketorolac Injection Sales Forecast by Type (2021-2025)
12.3.2 Global Ketorolac Injection Market Share Forecast by Type (2021-2025)
12.4 Ketorolac Injection Market Forecast by Application (2021-2025)
12.4.1 Global Ketorolac Injection Sales Forecast by Application (2021-2025)
12.4.2 Global Ketorolac Injection Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Ketorolac Injection Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ketorolac Injection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ketorolac Injection Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Ketorolac Injection Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Almaject Basic Information, Manufacturing Base and Competitors
Table 9. Almaject Ketorolac Injection Major Business
Table 10. Almaject Ketorolac Injection Total Revenue (USD Million) (2018-2019)
Table 11. Almaject SWOT Analysis
Table 12. Almaject Ketorolac Injection Product and Services
Table 13. Almaject Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Athenex Basic Information, Manufacturing Base and Competitors
Table 15. Athenex Ketorolac Injection Major Business
Table 16. Athenex Ketorolac Injection Total Revenue (USD Million) (2018-2019)
Table 17. Athenex SWOT Analysis
Table 18. Athenex Ketorolac Injection Product and Services
Table 19. Athenex Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Hikma Basic Information, Manufacturing Base and Competitors
Table 21. Hikma Ketorolac Injection Major Business
Table 22. Hikma Ketorolac Injection Total Revenue (USD Million) (2018-2019)
Table 23. Hikma SWOT Analysis
Table 24. Hikma Ketorolac Injection Product and Services
Table 25. Hikma Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Amphastar Basic Information, Manufacturing Base and Competitors
Table 27. Amphastar Ketorolac Injection Major Business
Table 28. Amphastar Ketorolac Injection Total Revenue (USD Million) (2018-2019)
Table 29. Amphastar SWOT Analysis
Table 30. Amphastar Ketorolac Injection Product and Services
Table 31. Amphastar Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Alvogen Basic Information, Manufacturing Base and Competitors
Table 33. Alvogen Ketorolac Injection Major Business
Table 34. Alvogen Ketorolac Injection Total Revenue (USD Million) (2018-2019)
Table 35. Alvogen SWOT Analysis
Table 36. Alvogen Ketorolac Injection Product and Services
Table 37. Alvogen Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 39. Fresenius Kabi Ketorolac Injection Major Business
Table 40. Fresenius Kabi Ketorolac Injection Total Revenue (USD Million) (2018-2019)
Table 41. Fresenius Kabi SWOT Analysis
Table 42. Fresenius Kabi Ketorolac Injection Product and Services
Table 43. Fresenius Kabi Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Fosun Pharma Basic Information, Manufacturing Base and Competitors
Table 45. Fosun Pharma Ketorolac Injection Major Business
Table 46. Fosun Pharma Ketorolac Injection Total Revenue (USD Million) (2018-2019)
Table 47. Fosun Pharma SWOT Analysis
Table 48. Fosun Pharma Ketorolac Injection Product and Services
Table 49. Fosun Pharma Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Sagent Basic Information, Manufacturing Base and Competitors
Table 51. Sagent Ketorolac Injection Major Business
Table 52. Sagent Ketorolac Injection Total Revenue (USD Million) (2018-2019)
Table 53. Sagent SWOT Analysis
Table 54. Sagent Ketorolac Injection Product and Services
Table 55. Sagent Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Pfizer Basic Information, Manufacturing Base and Competitors
Table 57. Pfizer Ketorolac Injection Major Business
Table 58. Pfizer Ketorolac Injection Total Revenue (USD Million) (2018-2019)
Table 59. Pfizer SWOT Analysis
Table 60. Pfizer Ketorolac Injection Product and Services
Table 61. Pfizer Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. BD RX Basic Information, Manufacturing Base and Competitors
Table 63. BD RX Ketorolac Injection Major Business
Table 64. BD RX Ketorolac Injection Total Revenue (USD Million) (2018-2019)
Table 65. BD RX SWOT Analysis
Table 66. BD RX Ketorolac Injection Product and Services
Table 67. BD RX Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Virtus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 69. Virtus Pharmaceuticals Ketorolac Injection Major Business
Table 70. Virtus Pharmaceuticals Ketorolac Injection Total Revenue (USD Million) (2018-2019)
Table 71. Virtus Pharmaceuticals SWOT Analysis
Table 72. Virtus Pharmaceuticals Ketorolac Injection Product and Services
Table 73. Virtus Pharmaceuticals Ketorolac Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Global Ketorolac Injection Sales by Manufacturer (2018-2019) (K Units)
Table 75. Global Ketorolac Injection Revenue by Manufacturer (2018-2019) (USD Million)
Table 76. Global Ketorolac Injection Sales by Regions (2015-2020) (K Units)
Table 77. Global Ketorolac Injection Sales Market Share by Regions (2015-2020)
Table 78. Global Ketorolac Injection Revenue by Regions (2015-2020) (USD Million)
Table 79. North America Ketorolac Injection Sales by Countries (2015-2020) (K Units)
Table 80. North America Ketorolac Injection Sales Market Share by Countries (2015-2020)
Table 81. North America Ketorolac Injection Revenue by Countries (2015-2020) (USD Million)
Table 82. North America Ketorolac Injection Revenue Market Share by Countries (2015-2020)
Table 83. Europe Ketorolac Injection Sales by Countries (2015-2020) (K Units)
Table 84. Europe Ketorolac Injection Sales Market Share by Countries (2015-2020)
Table 85. Europe Ketorolac Injection Revenue by Countries (2015-2020) (USD Million)
Table 86. Asia-Pacific Ketorolac Injection Sales by Regions (2015-2020) (K Units)
Table 87. Asia-Pacific Ketorolac Injection Sales Market Share by Regions (2015-2020)
Table 88. Asia-Pacific Ketorolac Injection Revenue by Regions (2015-2020) (USD Million)
Table 89. South America Ketorolac Injection Sales by Countries (2015-2020) (K Units)
Table 90. South America Ketorolac Injection Sales Market Share by Countries (2015-2020)
Table 91. South America Ketorolac Injection Revenue by Countries (2015-2020) (USD Million)
Table 92. South America Ketorolac Injection Revenue Market Share by Countries (2015-2020)
Table 93. Middle East & Africa Ketorolac Injection Sales by Countries (2015-2020) (K Units)
Table 94. Middle East & Africa Ketorolac Injection Sales Market Share by Countries (2015-2020)
Table 95. Middle East & Africa Ketorolac Injection Revenue by Countries (2015-2020) (USD Million)
Table 96. Middle East & Africa Ketorolac Injection Revenue Market Share by Countries (2015-2020)
Table 97. Global Ketorolac Injection Sales by Type (2015-2020) (K Units)
Table 98. Global Ketorolac Injection Sales Share by Type (2015-2020)
Table 99. Global Ketorolac Injection Revenue by Type (2015-2020) (USD Million)
Table 100. Global Ketorolac Injection Revenue Share by Type (2015-2020)
Table 101. Global Ketorolac Injection Sales by Application (2015-2020) (K Units)
Table 102. Global Ketorolac Injection Sales Share by Application (2015-2020)
Table 103. Global Ketorolac Injection Sales Forecast by Regions (2021-2025) (K Units)
Table 104. Global Ketorolac Injection Market Share Forecast by Regions (2021-2025)
Table 105. Global Ketorolac Injection Sales Forecast by Type (2021-2025) (K Units)
Table 106. Global Ketorolac Injection Market Share Forecast by Type (2021-2025)
Table 107. Global Ketorolac Injection Sales Forecast by Application (2021-2025)
Table 108. Global Ketorolac Injection Market Share Forecast by Application (2021-2025)
Table 109. Direct Channel Pros & Cons
Table 110. Indirect Channel Pros & Cons
Table 111. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Ketorolac Injection Picture
Figure 2. Global Sales Market Share of Ketorolac Injection by Type in 2019
Figure 3. 15mg/ml Picture
Figure 4. 30mg/ml Picture
Figure 5. Ketorolac Injection Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Clinics Picture
Figure 8. Recovery Center Picture
Figure 9. Global Ketorolac Injection Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Ketorolac Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Ketorolac Injection Sales Market Share by Manufacturer in 2019
Figure 30. Global Ketorolac Injection Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Ketorolac Injection Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Ketorolac Injection Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Ketorolac Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Ketorolac Injection Revenue Market Share by Regions (2015-2020)
Figure 37. Global Ketorolac Injection Revenue Market Share by Regions in 2018
Figure 38. North America Ketorolac Injection Sales and Growth Rate (2015-2020)
Figure 39. Europe Ketorolac Injection Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Ketorolac Injection Sales and Growth Rate (2015-2020)
Figure 41. South America Ketorolac Injection Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Ketorolac Injection Sales and Growth Rate (2015-2020)
Figure 43. North America Ketorolac Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Ketorolac Injection Sales Market Share by Countries (2015-2020)
Figure 45. North America Ketorolac Injection Sales Market Share by Countries in 2018
Figure 46. North America Ketorolac Injection Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Ketorolac Injection Revenue Market Share by Countries in 2018
Figure 48. United States Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Ketorolac Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Ketorolac Injection Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Ketorolac Injection Revenue Market Share by Countries in 2019
Figure 54. Germany Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Ketorolac Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Ketorolac Injection Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Ketorolac Injection Revenue Market Share by Regions 2019
Figure 62. China Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Ketorolac Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Ketorolac Injection Sales Market Share by Countries in 2019
Figure 69. South America Ketorolac Injection Revenue Market Share by Countries in 2019
Figure 70. Brazil Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Ketorolac Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Ketorolac Injection Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Ketorolac Injection Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Ketorolac Injection Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Ketorolac Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Ketorolac Injection Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Ketorolac Injection Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Ketorolac Injection Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Ketorolac Injection Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Ketorolac Injection Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Ketorolac Injection Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Ketorolac Injection Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
エナラプリラト注射の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Enalaprilat Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…- ヒヨスチアミン硫酸塩注射の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Hyoscyamine Sulfate Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- アミオダロン注射の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Amiodarone Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- ドキソルビシン注射の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Doxorubicin Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 50％ブドウ糖注射の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The 50% Dextrose Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…